France Set To Begin Two-Year Medical Cannabis Trial

France Set To Begin Two-Year Medical Cannabis Trial

France currently lags behind many other European nations when it comes to cannabis legislation, although the good news is that the government now seems determined to play catch-up by implementing a two-year-long medical marijuana trial. Clinicians will be allowed to prescribe a range of different cannabis products throughout the test period, while a national database will also be set up in order to record patient outcomes, with a view to informing future cannabis laws in France. The trial was originally approved by the government in October 2019 and had been scheduled to begin in September 2020, although this was postponed as the health authorities redirected all their resources toward combatting the COVID-19 pandemic. According to the most recent official announcement, the trial will now begin by January 2021 at the latest. Related Post The G7 Countries and Their Cannabis Policies What Will The Trial Entail? The National Agency for Drug Safety (ANSM) says that the purpose of the initiative is to allow patients suffering from certain conditions to try medical cannabis if they have failed to respond to other treatments. Among the conditions listed are neuropathic pain, treatment-resistant epilepsy, chemotherapy-related nausea and painful spasms caused by multiple sclerosis or other disorders of the central nervous system. Patients in palliative care will also be eligible for the programme. Cannabis products will be available on prescription only, and clinicians wishing to take part in the trial will need to undergo an online training course before they can start prescribing. A range of…

Excerpt only …
READ MORE BELOW
Source : seedman
Link to original : France Set To Begin Two-Year Medical Cannabis Trial
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.